Spyre Therapeutics Overview
Spyre Therapeutics Target Price
Analysts' 12-month price predictions for SYRE.
Get informed when a big investor buys or sells
+ FollowShare Price
$86.63
Average Target Price
$95.80
10.6% upside
10.6% upside15 analysts in the last 4 months
High: $135 | Low: $49
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-23 | Deutsche Bank | $135 | 55.8% upside |  |
| 2026-06-16 | Wedbush | $100 | 15.4% upside | |
| 2026-06-15 | BTIG | $112 | 29.3% upside | |
| 2026-06-04 | Deutsche Bank | $115 | 32.7% upside | |
| 2026-05-12 | Deutsche Bank | $102 | 17.7% upside | |
| 2026-05-06 | Stifel NicolausAlex Thompson | $107 | 23.5% upside | |
| 2026-04-14 | Wells Fargo | $90 | 3.9% upside | |
| 2026-04-14 | Deutsche Bank | $88 | 1.6% upside | |
| 2026-04-14 | Robert W. Baird | $90 | 3.9% upside | |
| 2026-04-13 | Raymond James | $80 |  7.7% downside | |
| 2026-04-13 | WedbushDavid Nierengarten | $80 | 7.7% downside | |
| 2026-04-13 | Leerink Partners | $106 | 22.4% upside | |
| 2026-04-13 | BTIGJulian Harrison | $98 | 13.1% upside | |
| 2026-04-13 | Jefferies | $85 | 1.9% downside | |
| 2026-03-16 | William Blair | $49 | 43.4% downside | |
| 2025-12-17 | Mizuho Securities | $53 | 38.8% downside | |
| 2025-09-26 | Deutsche Bank | $43 | 50.4% downside | |
| 2024-11-12 | Stifel NicolausAlex Thompson | $71 | 18% downside | |
| 2024-10-17 | Robert W. BairdColleen Kusy | $50 | 42.3% downside | |
| 2024-10-15 | Wells FargoYanan Zhu | $40 | 53.8% downside | |
| 2024-05-10 | BTIGJulian Harrison | $40 | 53.8% downside | |